dexmedetomidine has been researched along with carbostyril in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, K; Zhu, Y | 1 |
1 other study(ies) available for dexmedetomidine and carbostyril
Article | Year |
---|---|
Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway.
Topics: Analgesics, Non-Narcotic; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Gene Expression Regulation, Neoplastic; Glucose; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Oxygen; p38 Mitogen-Activated Protein Kinases; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Quinolones; Signal Transduction | 2018 |